Sunstar Americas
11
0
0
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 70/100
27.3%
3 terminated/withdrawn out of 11 trials
72.7%
-13.8% vs industry average
9%
1 trials in Phase 3/4
138%
11 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Evaluation of Toothbrush Bristles in Plaque Reduction
Role: lead
Clinical Evaluation of Oral Rinse for Xerostomia
Role: lead
Efficacy of Synthetic Bone Graft for Treatment of Peri-implantitis
Role: lead
Ridge Preservation With Moldable Beta-tricalcium Phosphate Bone Substitute on Non-containable Non-Molar Extraction Sites
Role: lead
Assessment of Ridge Preservation Using Moldable Beta-tricalcium Phosphate Bone Grafting System
Role: lead
GUIDOR® Growth Factor Enhanced Bone Graft Substitute for the Treatment of Periodontal Defects 6-months Post-Surgery
Role: lead
Prospective, Comparative Assessment of Alveolar Bone Augmentation Using GUIDOR® Membrane in the Bound Edentulous Space
Role: collaborator
Curved Soft-Picks on Plaque Accumulation on Patients With Gingivitis
Role: lead
A Clinical Trial to Evaluate Long-term Efficacy and Safety of Lozenges Containing Lactobacilli Reuteri (Prodentis™) on Gingivitis
Role: lead
Case Series of New Alloplastic Bone Graft Material
Role: lead
Periocline as an Adjunct to Scaling and Root Planing for Adult Periodontitis
Role: lead
All 11 trials loaded